Clinical Scorecard: What Will Redefine Pathology in 2026?

At a Glance

Key Highlights

• Increased adoption of AI in R&D for hypothesis generation and experiment design.
• Long-read sequencing to address complex repeat expansion disorders.
• Emergence of population-specific genomic projects worldwide.
• Integration of biological modeling in early discovery processes.
• Mainstream use of digital twins in clinical development.

Guideline-Based Recommendations

Diagnosis

• Utilize long-read sequencing for complex genetic disorders.

Management

• Adopt AI-guided platforms for target identification in biologics.

Monitoring & Follow-up

• Implement digital twins for optimizing clinical trial protocols.

Risks

• Ensure rigorous validation and ethical governance of AI tools.

Patient & Prescribing Data

Individuals with genetic disorders and those participating in clinical trials.

Focus on personalized medicine through inclusive genomic data.

Clinical Best Practices

• Integrate AI tools into R&D workflows for enhanced efficiency.
• Promote collaboration among regulators, sponsors, and technology partners.
• Utilize biological modeling to improve candidate selection in drug discovery.

References